These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 16438160

  • 21. Prevalence of von Willebrand disease in women with iron deficiency anaemia and menorrhagia in Taiwan.
    Chen YC, Chao TY, Cheng SN, Hu SH, Liu JY.
    Haemophilia; 2008 Jul; 14(4):768-74. PubMed ID: 18498402
    [Abstract] [Full Text] [Related]

  • 22. Dominant von Willebrand disease type 2M and 2U are variable expressions of one distinct disease entity caused by loss-of-function mutations in the A1 domain of the von Willebrand factor gene.
    Gadisseur A, van der Planken M, Schroyens W, Berneman Z, Michiels JJ.
    Acta Haematol; 2009 Jul; 121(2-3):145-53. PubMed ID: 19506361
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Recessive von Willebrand disease type 2 Normandy: variable expression of mild hemophilia and VWD type 1.
    Michiels JJ, Gadisseur A, Vangenegten I, Schroyens W, Berneman Z.
    Acta Haematol; 2009 Jul; 121(2-3):119-27. PubMed ID: 19506358
    [Abstract] [Full Text] [Related]

  • 25. PFA-100 monitoring of von Willebrand factor (VWF) responses to desmopressin (DDAVP) and factor VIII/VWF concentrate substitution in von Willebrand disease type 1 and 2.
    van Vliet HH, Kappers-Klunne MC, Leebeek FW, Michiels JJ.
    Thromb Haemost; 2008 Sep; 100(3):462-8. PubMed ID: 18766263
    [Abstract] [Full Text] [Related]

  • 26. An update on the von Willebrand factor collagen binding assay: 21 years of age and beyond adolescence but not yet a mature adult.
    Favaloro EJ.
    Semin Thromb Hemost; 2007 Nov; 33(8):727-44. PubMed ID: 18175279
    [Abstract] [Full Text] [Related]

  • 27. Intravenous DDAVP and factor VIII-von Willebrand factor concentrate for the treatment and prophylaxis of bleedings in patients With von Willebrand disease type 1, 2 and 3.
    Michiels JJ, van Vliet HH, Berneman Z, Gadisseur A, van der Planken M, Schroyens W, van der Velden A, Budde U.
    Clin Appl Thromb Hemost; 2007 Jan; 13(1):14-34. PubMed ID: 17164493
    [Abstract] [Full Text] [Related]

  • 28. Lower limit of assay sensitivity: an under-recognised and significant problem in von Willebrand disease identification and classification.
    Favaloro EJ, Bonar R, Marsden K.
    Clin Lab Sci; 2008 Jan; 21(3):178-83. PubMed ID: 18678140
    [Abstract] [Full Text] [Related]

  • 29. Comparative analysis and classification of von Willebrand factor/factor VIII concentrates: impact on treatment of patients with von Willebrand disease.
    Budde U, Metzner HJ, Müller HG.
    Semin Thromb Hemost; 2006 Sep; 32(6):626-35. PubMed ID: 16977573
    [Abstract] [Full Text] [Related]

  • 30. Relationship between ABO and Secretor genotype with plasma levels of factor VIII and von Willebrand factor in thrombosis patients and control individuals.
    Schleef M, Strobel E, Dick A, Frank J, Schramm W, Spannagl M.
    Br J Haematol; 2005 Jan; 128(1):100-7. PubMed ID: 15606555
    [Abstract] [Full Text] [Related]

  • 31. Development and applications of surface plasmon resonance-based von Willebrand factor-collagen binding assay.
    Saenko E, Kannicht C, Loster K, Sarafanov A, Khrenov A, Kouiavskaia D, Shima M, Ananyeva N, Schwinn H, Gruber G, Josic D.
    Anal Biochem; 2002 Mar 15; 302(2):252-62. PubMed ID: 11878805
    [Abstract] [Full Text] [Related]

  • 32. [Von Willebrand factor in hemodialysed patients with chronic renal failure].
    Bronisz M, Rość D, Paczuski R, Nartowicz E, Bronisz A.
    Pol Merkur Lekarski; 2001 Jul 15; 11(61):40-3. PubMed ID: 11579829
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Genetics of type 1 von Willebrand disease.
    Goodeve A.
    Curr Opin Hematol; 2007 Sep 15; 14(5):444-9. PubMed ID: 17934350
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Protein C, protein S and von Willebrand factor levels correlate with bleeding symptoms: a population-based study.
    Rojnuckarin P, Uaprasert N, Akkawat B, Settapiboon R, Nanakorn T, Intragumtornchai T.
    Haemophilia; 2012 May 15; 18(3):457-62. PubMed ID: 22059727
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Autosomal dominant von Willebrand disease type 2M.
    Hermans C, Batlle J.
    Acta Haematol; 2009 May 15; 121(2-3):139-44. PubMed ID: 19506360
    [Abstract] [Full Text] [Related]

  • 40. Genetics of plasma concentration of von Willebrand factor.
    Orstavik KH.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1990 May 15; 117(4):527-31. PubMed ID: 1714855
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.